Skip to main content
Microbiology Resource Announcements logoLink to Microbiology Resource Announcements
. 2018 Dec 13;7(23):e01421-18. doi: 10.1128/MRA.01421-18

Draft Genome Sequence of French Guiana Leishmania (Viannia) guyanensis Strain 204-365, Assembled Using Long Reads

Dhwani Batra b, Wuling Lin a,c, Lori A Rowe b, Mili Sheth b, Yueli Zheng a,d, Vladimir Loparev b, Marcos de Almeida a,
Editor: Catherine Putontie
PMCID: PMC6298554  PMID: 30574587

We present here the draft genome sequence for Leishmania (Viannia) guyanensis. The isolate was obtained from a clinical case of cutaneous leishmaniasis in French Guiana.

ABSTRACT

We present here the draft genome sequence for Leishmania (Viannia) guyanensis. The isolate was obtained from a clinical case of cutaneous leishmaniasis in French Guiana. Genomic DNA was sequenced using PacBio and MiSeq platforms.

ANNOUNCEMENT

Human leishmaniasis is a spectrum of diseases of public health concern which affects millions of people, causing thousands of deaths worldwide (1, 2). Cutaneous leishmaniasis (CL) is the most prevalent clinical manifestation of the disease caused by several Leishmania parasites in the Leishmania and Viannia subgenera, which may put patients at risk of developing other forms of the disease (3). Mucocutaneous leishmaniasis (MCL) is a sequela that affects mucosal tissues of the respiratory and alimentary tracts, resulting in severe facial deformities. MCL may occur via the recurrence of misdiagnosed and/or suboptimal/not treated cases of CL caused by some species in the Viannia subgenus (47). Therefore, species-specific diagnosis is often critical for clinical management, i.e., prognosis of the disease’s progression, treatment options, and how to monitor for relapse and sequelae (8, 9). However, as the development of species-level diagnostic tests for clinical application depends on a robust genomic database, we are working on identifying species-specific targets by sequencing and comparing the genomes of several Leishmania species. Here, we describe the draft genome sequence of L. (V.) guyanensis, which was isolated from a clinical case of cutaneous leishmaniasis in French Guiana in 2004. The strain was identified using our traditional diagnostic approach (10, 11) and by comparing the sequence of Leishmania sp. genes P6GD, ICD, MDH, and MPI generated on an ABI 3130xl DNA analyzer (Applied Biosystems, CA), with the NCBI nucleotide database using BLAST.

Genomic DNA was extracted from parasites cultured in RPMI 1640 axenic medium (Life Technologies, CA) using the MagAttract high-molecular-weight (HMW) DNA kit (Qiagen, MD), following the manufacturer’s instructions, and DNA quality was evaluated using the 2200 TapeStation system (Agilent Technologies, DE). Dual-indexed sequencing libraries were prepared using NEBNext Ultra library prep reagents (New England BioLabs, MA) and barcoding indices synthesized by the CDC’s Biotechnology Core Facility. Sequencing was performed on a MiSeq platform (Illumina, CA) using the MiSeq 2 × 250-cycle sequencing kit. Upon completion, sequence reads were filtered for read quality, basecalled, and demultiplexed using default settings for bcl2fastq (version 2.19), resulting in 13,902,528 reads. In addition, a 20-kb DNA library was prepared following the standard PacBio 20-kb procedure (Pacific Biosciences, CA) and size selected with BluePippin (Sage Science, MA). The final size-selected library was bound to polymerase using the DNA/polymerase binding kit P6 version 2, loaded onto 5 single-molecule real-time (SMRT) cells, and sequenced with C4 version 2 chemistry for 360-min movies on the RS II instrument (Pacific Biosciences) to obtain 251,394 reads, with a mean read length of 12,942 bp after using default filter settings.

The PacBio reads were de novo assembled (80× coverage; GC content, 57%) using Canu version 1.6 (12) (minReadLength = 5,000, minOverlapLength = 1,000), and very low-coverage (<10×) contigs were removed from the assembly. Illumina reads were used to polish and correct contigs using unicycler_polish (Unicycler package version 4.4) (12, 13).

As shown in Table 1, the proposed assembly is significantly contiguous in comparison to the previously published short-read assembly of the L. (V.) guyanensis LgCL085 genome (14).

TABLE 1.

Assembly metrics for L. guyanensis 204-365 and LgCL085a

Characteristic 204-365 contigs LgCL085 scaffolds LgCL085 contigs
No. 123 270 1,734
Total size (bp) 33,816,023 31,014,322 30,875,308
Longest (bp) 2,583,876 2,586,957 307,213
Shortest (bp) 12,939 1,009 48
Mean size (bp) 274,927 114,868 17,806
Medium size (bp) 47,844 4,383 5,985
N50 length (bp) 683,170 967,189 47,920
L50 16 11 182
a

See reference 14.

Data availability.

The genome contigs of L. (V.) guyanensis 204-365 have been deposited in GenBank under accession number QVNO00000000, SRA accession numbers SRR7867261, SRR7867262, SRR7867269, SRR7867270, SRR7867271, and SRR8179913, and BioProject number PRJNA484340.

ACKNOWLEDGMENT

This work was made possible through support from the CDC’s Advanced Molecular Detection (AMD) program.

REFERENCES

  • 1.Desjeux P. 2004. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305–318. doi: 10.1016/j.cimid.2004.03.004. [DOI] [PubMed] [Google Scholar]
  • 2.Herwaldt BL. 1999. Leishmaniasis. Lancet 354:1191–1199. doi: 10.1016/S0140-6736(98)10178-2. [DOI] [PubMed] [Google Scholar]
  • 3.Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho E, Ephros M, Jeronimo S, Magill A. 2017. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg 96:24–45. doi: 10.4269/ajtmh.16-84256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Diniz JL, Costa MO, Gonçalves DU. 2011. Mucocutaneous leishmaniasis: clinical markers in presumptive diagnosis. Braz J Otorhinolaryngol 77:380–384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.David CV, Craft N. 2009. Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther 22:491–502. doi: 10.1111/j.1529-8019.2009.01272.x. [DOI] [PubMed] [Google Scholar]
  • 6.Guerra JAdO, Prestes SR, Silveira H, Coelho LIdARC, Gama P, Moura A, Amato V, Barbosa M, Ferreira LCdL. 2011. Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon. PLoS Negl Trop Dis 5:e980. doi: 10.1371/journal.pntd.0000980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ronet C, Beverley SM, Fasel N. 2011. Muco-cutaneous leishmaniasis in the New World: the ultimate subversion. Virulence 2:547–552. doi: 10.4161/viru.2.6.17839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.de Vries HJC, Reedijk SH, Schallig HDFH. 2015. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol 16:99–109. doi: 10.1007/s40257-015-0114-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA. 2015. Cutaneous and mucocutaneous leishmaniasis: clinical perspectives. J Am Acad Dermatol 73:897–908. doi: 10.1016/j.jaad.2014.08.051. [DOI] [PubMed] [Google Scholar]
  • 10.de Almeida ME, Koru O, Steurer F, Herwaldt BL, da Silva AJ. 2017. Detection and differentiation of Leishmania spp. in clinical specimens by use of a SYBR green-based real-time PCR assay. J Clin Microbiol 55:281–290. doi: 10.1128/JCM.01764-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.de Almeida ME, Steurer FJ, Koru O, Herwaldt BL, Pieniazek NJ, da Silva AJ. 2011. Identification of Leishmania spp. by molecular amplification and DNA sequencing analysis of a fragment of rRNA internal transcribed spacer 2. J Clin Microbiol 49:3143–3149. doi: 10.1128/JCM.01177-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Koren S, Walenz BP, Berlin K, Miller JR, Bergman NH, Phillippy AM. 2017. Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res 27:722–736. doi: 10.1101/gr.215087.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. doi: 10.1371/journal.pcbi.1005595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Coughlan S, Taylor AS, Feane E, Sanders M, Schonian G, Cotton JA, Downing T. 2018. Leishmania naiffi and Leishmania guyanensis reference genomes highlight genome structure and gene evolution in the Viannia subgenus. R Soc Open Sci 5:172212. doi: 10.1098/rsos.172212. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The genome contigs of L. (V.) guyanensis 204-365 have been deposited in GenBank under accession number QVNO00000000, SRA accession numbers SRR7867261, SRR7867262, SRR7867269, SRR7867270, SRR7867271, and SRR8179913, and BioProject number PRJNA484340.


Articles from Microbiology Resource Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES